➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Baxter
Harvard Business School
McKinsey
Express Scripts

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

NORTRIPTYLINE HYDROCHLORIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for nortriptyline hydrochloride and what is the scope of patent protection?

Nortriptyline hydrochloride is the generic ingredient in four branded drugs marketed by Lilly, Ani Pharms, Aurolife Pharma Llc, Mayne Pharma, Mylan, Taro, Teva, Zydus, Specgx Llc, Ranbaxy, and Pharm Assoc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for nortriptyline hydrochloride. Twenty-three suppliers are listed for this compound.

Summary for NORTRIPTYLINE HYDROCHLORIDE
Recent Clinical Trials for NORTRIPTYLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lancaster General HospitalPhase 4
University of California, IrvinePhase 4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 2

See all NORTRIPTYLINE HYDROCHLORIDE clinical trials

Pharmacology for NORTRIPTYLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for NORTRIPTYLINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for NORTRIPTYLINE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
PAMELOR CAPSULE;ORAL nortriptyline hydrochloride 018013

US Patents and Regulatory Information for NORTRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurolife Pharma Llc NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074835-004 Jun 30, 1997 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mayne Pharma NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 073556-002 Mar 30, 1992 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Zydus NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 213441-004 Feb 24, 2021 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074234-003 Jul 26, 1993 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 073667-001 Apr 11, 1996 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074132-001 Mar 27, 1995 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pharm Assoc NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride SOLUTION;ORAL 075606-001 Aug 28, 2000 AA RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NORTRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-003 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-001 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-004 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-002 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Specgx Llc PAMELOR nortriptyline hydrochloride SOLUTION;ORAL 018012-001 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Baxter
Harvard Business School
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.